{"id":"https://openalex.org/W2575273748","doi":"https://doi.org/10.1182/blood.v114.22.1048.1048","title":"High Dose Cytarabine (HiDAC) and Mitoxantrone (MITO) Is An Effective Induction Therapy for High-Risk Acute Myeloid Leukemia (AML).","display_name":"High Dose Cytarabine (HiDAC) and Mitoxantrone (MITO) Is An Effective Induction Therapy for High-Risk Acute Myeloid Leukemia (AML).","publication_year":2009,"publication_date":"2009-11-20","ids":{"openalex":"https://openalex.org/W2575273748","doi":"https://doi.org/10.1182/blood.v114.22.1048.1048","mag":"2575273748"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v114.22.1048.1048","doi":"https://doi.org/10.1182/blood.v114.22.1048.1048","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v114.22.1048.1048","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041161932","display_name":"Sarah Marie Larson","orcid":"https://orcid.org/0000-0002-4335-2925","observed_orcids":["https://orcid.org/0000-0002-4335-2925"]},"institutions":[{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sarah Larson","raw_affiliation_strings":["University Of Chicago Medical Center, Chicago, IL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Of Chicago Medical Center, Chicago, IL, USA,","institution_ids":["https://openalex.org/I4210087865"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112319845","display_name":"Nicholas Paul Campbell","orcid":"https://orcid.org/0009-0007-0358-1647","observed_orcids":["https://orcid.org/0009-0007-0358-1647"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nicholas Campbell","raw_affiliation_strings":["Hematology/Oncology, University of Chicago, Chicago, IL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, University of Chicago, Chicago, IL, USA,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015502083","display_name":"Dezheng Huo","orcid":"https://orcid.org/0000-0002-4041-1678","observed_orcids":["https://orcid.org/0000-0002-4041-1678","https://orcid.org/0000-0002-0021-5699"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Dezheng Huo","raw_affiliation_strings":["University of Chicago, Chicago, IL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL, USA,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057523501","display_name":"Andrew S. Artz","orcid":"https://orcid.org/0000-0003-0803-9607","observed_orcids":["https://orcid.org/0000-0003-0803-9607"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Artz","raw_affiliation_strings":["University of Chicago Hospital, Chicago, IL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago Hospital, Chicago, IL, USA,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100604286","display_name":"Yanming Zhang","orcid":"https://orcid.org/0000-0002-1391-9572","observed_orcids":["https://orcid.org/0000-0002-1391-9572"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Yanming Zhang","raw_affiliation_strings":["Dept. of Medicine, The University of Chicago, Chicago, IL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Medicine, The University of Chicago, Chicago, IL, USA,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019910948","display_name":"Devika Gajria","orcid":"https://orcid.org/0009-0009-9591-7025","observed_orcids":["https://orcid.org/0009-0009-9591-7025"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Devika Gajria","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, Education and Training, Medical Oncology, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, Education and Training, Medical Oncology, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112279481","display_name":"Margaret Green","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Margaret Green","raw_affiliation_strings":["University of Chicago Medical Center, Chicago, IL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago Medical Center, Chicago, IL, USA,","institution_ids":["https://openalex.org/I4210087865"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028709988","display_name":"Gamar Rahimova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Gamar Rahimova","raw_affiliation_strings":["Hematology/Oncology, University of Chicago, Chicago, IL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, University of Chicago, Chicago, IL, USA,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Howard Weiner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Howard Weiner","raw_affiliation_strings":["Hematology/Oncology, University of Chicago, Chicago, IL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, University of Chicago, Chicago, IL, USA,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Monica Torres","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Monica Torres","raw_affiliation_strings":["Hematology/Oncology, University of Chicago, Chicago, IL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, University of Chicago, Chicago, IL, USA,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060015628","display_name":"Olatoyosi M. Odenike","orcid":"https://orcid.org/0000-0002-4027-4124","observed_orcids":["https://orcid.org/0000-0002-4027-4124"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olatoyosi Odenike","raw_affiliation_strings":["University of Chicago, Chicago, IL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL, USA,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065240782","display_name":"Lucy A. Godley","orcid":"https://orcid.org/0000-0003-1914-9158","observed_orcids":["https://orcid.org/0000-0003-1914-9158"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lucy A Godley","raw_affiliation_strings":["Univ. of Chicago Med. Ctr., Chicago, IL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. of Chicago Med. Ctr., Chicago, IL, USA,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028012131","display_name":"Elizabeth Shima Rich","orcid":"https://orcid.org/0000-0002-3322-5359","observed_orcids":["https://orcid.org/0000-0002-3322-5359"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Shima Rich","raw_affiliation_strings":["University of Chicago, Chicago, IL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL, USA,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033996214","display_name":"Michael J. Thirman","orcid":"https://orcid.org/0000-0001-5154-9499","observed_orcids":["https://orcid.org/0000-0001-5154-9499"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Thirman","raw_affiliation_strings":["Medicine, University of Chicago, Chicago, IL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, University of Chicago, Chicago, IL, USA,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072420982","display_name":"Richard A. Larson","orcid":"https://orcid.org/0000-0001-9168-3203","observed_orcids":["https://orcid.org/0000-0001-9168-3203"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard A. Larson","raw_affiliation_strings":["University of Chicago, Chicago, IL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL, USA,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005939966","display_name":"Wendy Stock","orcid":"https://orcid.org/0000-0002-8349-9200","observed_orcids":["https://orcid.org/0000-0002-8349-9200"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wendy Stock","raw_affiliation_strings":["Section Hem./Onc., University of Chicago, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section Hem./Onc., University of Chicago, Chicago, IL, USA","institution_ids":["https://openalex.org/I40347166"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5015502083","https://openalex.org/A5019910948","https://openalex.org/A5028709988","https://openalex.org/A5041161932","https://openalex.org/A5100604286","https://openalex.org/A5112279481","https://openalex.org/A5112319845"],"corresponding_institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40347166","https://openalex.org/I4210087865"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.4261,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.71408935,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"114","issue":"22","first_page":"1048","last_page":"1048"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/high-dose-cytarabine","display_name":"high-dose cytarabine","score":0.9160000085830688},{"id":"https://openalex.org/keywords/mitoxantrone","display_name":"mitoxantrone","score":0.972000002861023},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8460000157356262},{"id":"https://openalex.org/keywords/induction-chemotherapy","display_name":"induction chemotherapy","score":0.7549999952316284},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.7820000052452087},{"id":"https://openalex.org/keywords/induction-mortality","display_name":"induction mortality","score":0.6980000138282776},{"id":"https://openalex.org/keywords/adverse-cytogenetics","display_name":"adverse cytogenetics","score":0.574999988079071},{"id":"https://openalex.org/keywords/therapy-related-myeloid-neoplasms","display_name":"therapy-related myeloid neoplasms","score":0.8259999752044678},{"id":"https://openalex.org/keywords/myelodysplasia-related-changes","display_name":"myelodysplasia-related changes","score":0.8059999942779541},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.5440000295639038},{"id":"https://openalex.org/keywords/refractory-aml","display_name":"refractory AML","score":0.5239999890327454},{"id":"https://openalex.org/keywords/relapsed-aml","display_name":"relapsed AML","score":0.6169999837875366},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.453000009059906}],"concepts":[{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.8453158140182495},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7958033680915833},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6660307049751282},{"id":"https://openalex.org/C2780923524","wikidata":"https://www.wikidata.org/wiki/Q239426","display_name":"Mitoxantrone","level":3,"score":0.6314691305160522},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4992563724517822},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.46779757738113403},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.46218857169151306},{"id":"https://openalex.org/C2776611710","wikidata":"https://www.wikidata.org/wiki/Q16888295","display_name":"Induction chemotherapy","level":3,"score":0.44534602761268616},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.4285963177680969},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4010718762874603},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.385816365480423},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3711477518081665}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v114.22.1048.1048","doi":"https://doi.org/10.1182/blood.v114.22.1048.1048","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v114.22.1048.1048","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2124938739","https://openalex.org/W2589011397","https://openalex.org/W2794035422","https://openalex.org/W2001901510","https://openalex.org/W2920987789","https://openalex.org/W2891684308","https://openalex.org/W1536183960","https://openalex.org/W2591223195","https://openalex.org/W2956113889","https://openalex.org/W3214903046"],"abstract_inverted_index":{"Abstract":[0,1],"1048":[2],"Poster":[3],"Board":[4],"I-70":[5],"Background:":[6],"Patients":[7,107,270],"with":[8,14,97,108,271,273,317,424],"high":[9,109,348,417],"risk":[10,110,349,383,418],"AML,":[11],"including":[12],"those":[13,96],"advanced":[15],"age,":[16],"relapsed":[17],"or":[18],"refractory":[19,261],"disease,":[20],"unfavorable":[21],"cytogenetics,":[22,241],"therapy-related":[23],"myeloid":[24],"neoplasm":[25],"(t-MN),":[26],"and":[27,35,51,55,149,173,183,247,264,285,295,300,311,321,357,365,385,394,403,421],"multiple":[28,386],"medical":[29,387],"co-morbidities,":[30],"carry":[31],"a":[32,64,88,221,280,291,373],"poor":[33],"prognosis":[34],"outcomes":[36],"after":[37,335],"7+3":[38],"induction":[39,56,187,265,301,353,367],"chemotherapy":[40],"are":[41],"poor.":[42],"Complete":[43],"remission":[44,206],"(CR)":[45],"rates":[46,58,303],"tend":[47],"to":[48,139,158,278,289,305,329,378,380,432],"be":[49],"low":[50,366],"range":[52,59],"from":[53,60,102],"12-63%":[54],"death":[57,188,191,266,302,368],"10-26%.":[61],"We":[62,86],"developed":[63],"novel,":[65],"timed-sequential":[66],"regimen":[67,414],"that":[68],"takes":[69],"advantage":[70],"of":[71,91,178,195,197,217,229,268,326,363,370,376,412,430],"synergy":[72],"when":[73],"MITO":[74],"follows":[75],"cytarabine":[76,130],"(VW":[77],"Quinones":[78],"et":[79],"al.":[80],"ASH":[81],"1996.":[82],"abstr":[83],"849).":[84],"Methods:":[85],"performed":[87],"retrospective":[89],"analysis":[90],"all":[92],"AML":[93,111,272,308,350,406],"patients,":[94,407],"except":[95],"t(15;17),":[98],"who":[99],"received":[100,129,203],"HiDAC/MITO":[101,204,352],"2001-2008":[103],"at":[104,117,131,153,340],"our":[105],"institution.":[106],"defined":[112,189],"by":[113,186],"age":[114,210],">60":[115,143],"and/or":[116],"least":[118],"two":[119],"adverse":[120],"prognostic":[121],"features":[122],"(cytogenetics,":[123],"co-morbid":[124],"conditions,":[125],"antecedent":[126],"hematologic":[127],"disorder)":[128],"3gm/m2":[132],"over":[133,163],"four":[134],"hours":[135],"(with":[136,155],"dose":[137,156],"reduction":[138,157],"2gm/m2":[140],"for":[141,160,205,415],"patients":[142,161,202,219,238,297,327,377,423],"years":[144,213],"old)":[145],"on":[146,170],"days":[147,171,194],"1":[148,172],"5":[150,248],"plus":[151],"mitoxantrone":[152],"30mg/m2":[154],"20mg/m2":[159],">60)":[162],"one":[164,341],"hour":[165],"immediately":[166],"following":[167],"the":[168,179,234,395,410],"HiDAC":[169],"5.":[174],"The":[175,208,227],"primary":[176],"endpoints":[177],"study":[180],"were":[181,286,313],"CR":[182,254,282,299,392,396],"toxicity":[184],"determined":[185],"as":[190],"within":[192],"30":[193],"initiation":[196],"treatment.":[198],"Results:":[199],"78":[200],"consecutive":[201],"induction.":[207],"median":[209],"was":[211,256,343,354,398],"63":[212],"(range":[214],"23-85);":[215],"27%":[216],"these":[218],"had":[220,239,244,250,298],"Charlson":[222],"comorbidity":[223],"index":[224],"(CCI)":[225],">2.":[226],"distribution":[228],"diagnoses":[230],"is":[231],"shown":[232],"in":[233],"Table.":[235],"43":[236],"(56%)":[237],"poor-risk":[240],"28":[242],"(37%)":[243],"intermediate-risk":[245],"cytogenetics":[246,384],"(7%)":[249],"good-risk":[251],"cytogenetics.":[252],"Overall":[253,338],"rate":[255,259,262,267,283,362,369,397],"45%,":[257],"CRi":[258],"10%,":[260],"36%,":[263],"9%.":[269],"myelodysplasia":[274],"related":[275],"changes":[276],"tended":[277],"have":[279,290],"lower":[281],"(p=0.07)":[284],"more":[287],"likely":[288],"CRi.":[292],"Notably,":[293],"t-MN":[294,402],"relapsed/refractory":[296,422],"equivalent":[304],"de":[306,404],"novo":[307,405],"patients.":[309],"Cytogenetics":[310],"CCI":[312],"also":[314],"not":[315,390],"associated":[316],"best":[318],"response,":[319],"p=0.7":[320],"0.94,":[322],"respectively.":[323],"Forty":[324],"percent":[325],"proceeded":[328],"allogeneic":[330],"stem":[331],"cell":[332],"transplantation":[333],"(alloSCT)":[334],"receiving":[336],"HiDAC/MITO.":[337],"survival":[339],"year":[342],"39%.":[344],"Conclusions:":[345],"In":[346],"this":[347,413],"population,":[351],"well":[355],"tolerated":[356],"demonstrated":[358],"an":[359],"overall":[360],"response":[361],"55%":[364],"9%,":[371],"allowing":[372],"substantial":[374],"number":[375],"proceed":[379],"alloSCT.":[381],"High":[382],"co-morbidities":[388],"did":[389],"affect":[391],"rate,":[393],"similar":[399],"among":[400],"relapsed/refractory,":[401],"which":[408],"highlights":[409],"utility":[411],"both":[416],"newly":[419],"diagnosed":[420],"AML.":[425],"Disclosures:":[426],"No":[427],"relevant":[428],"conflicts":[429],"interest":[431],"declare.":[433]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2017-01-26T00:00:00"}